Cargando…
What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292524/ https://www.ncbi.nlm.nih.gov/pubmed/34523249 http://dx.doi.org/10.1111/1756-185X.14214 |
| _version_ | 1784749392121561088 |
|---|---|
| author | Iolascon, Giovanni |
| author_facet | Iolascon, Giovanni |
| author_sort | Iolascon, Giovanni |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9292524 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92925242022-07-20 What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary Iolascon, Giovanni Int J Rheum Dis Cochrane Corner John Wiley and Sons Inc. 2021-09-14 2021-10 /pmc/articles/PMC9292524/ /pubmed/34523249 http://dx.doi.org/10.1111/1756-185X.14214 Text en © 2021 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Cochrane Corner Iolascon, Giovanni What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title | What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title_full | What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title_fullStr | What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title_full_unstemmed | What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title_short | What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary |
| title_sort | what are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: a cochrane review summary with commentary |
| topic | Cochrane Corner |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292524/ https://www.ncbi.nlm.nih.gov/pubmed/34523249 http://dx.doi.org/10.1111/1756-185X.14214 |
| work_keys_str_mv | AT iolascongiovanni whatarethebenefitsandharmsofbelimumabforpatientswithsystemiclupuserythematosusacochranereviewsummarywithcommentary |